Frontmatter

Home Frontmatter

Article Publicly Available

Published/Copyright: October 4, 2016

Published by

Become an author with De Gruyter Brill

Submit Manuscript Author Information Explore this Subject

"Frontmatter" Pleura and Peritoneum, vol. 1, no. 3, 2016, pp. i-iii. https://doi.org/10.1515/pp-2016-frontmatter3

(2016). Frontmatter. Pleura and Peritoneum, 1(3), i-iii. https://doi.org/10.1515/pp-2016-frontmatter3

(2016) Frontmatter. Pleura and Peritoneum, Vol. 1 (Issue 3), pp. i-iii. https://doi.org/10.1515/pp-2016-frontmatter3

"Frontmatter" Pleura and Peritoneum 1, no. 3 (2016): i-iii. https://doi.org/10.1515/pp-2016-frontmatter3

Frontmatter. Pleura and Peritoneum. 2016;1(3): i-iii. https://doi.org/10.1515/pp-2016-frontmatter3

Copied to clipboard

Published Online: 2016-10-04

Published in Print: 2016-10-01

Articles in the same Issue

Frontmatter
Editorial
The emerging role of chemosensitivity and resistance testing in malignant effusions
Reviews
Chemosensitivity and resistance testing in malignant effusions with focus on primary malignant mesothelioma and metastatic adenocarcinoma
Mesothelial cell transplantation: history, challenges and future directions
Functional vascular anatomy of the peritoneum in health and disease
Research Article
Bidirectional chemotherapy in gastric cancer with peritoneal metastasis combining intravenous XELOX with intraperitoneal chemotherapy with low-dose cisplatin and Doxorubicin administered as a pressurized aerosol: an open-label, Phase-2 study (PIPAC-GA2)

Search journal Search the content of this journal

Frontmatter
Editorial
The emerging role of chemosensitivity and resistance testing in malignant effusions
Reviews
Chemosensitivity and resistance testing in malignant effusions with focus on primary malignant mesothelioma and metastatic adenocarcinoma
Mesothelial cell transplantation: history, challenges and future directions
Functional vascular anatomy of the peritoneum in health and disease
Research Article
Bidirectional chemotherapy in gastric cancer with peritoneal metastasis combining intravenous XELOX with intraperitoneal chemotherapy with low-dose cisplatin and Doxorubicin administered as a pressurized aerosol: an open-label, Phase-2 study (PIPAC-GA2)